Sie befinden sind hier: Startseite > Börse > Unternehmensnachrichten > Innovative Molecules Completes Enrollment of Phase ...

Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

07.08.2025 - 18:06:12

Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250. Innovative Molecules GmbH United Kingdom England Germany Italy United States of America California

View original content:https://www.prnewswire.co.uk/news-releases/innovative-molecules-completes-enrollment-of-phase-1b-clinical-trial-of-im-250-302482334.html

@ prnewswire.co.uk

Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

Aktienkurse

Nachrichten

broker

Service

Weitere Angebote

Kursinformationen